Link between GIP and osteopontin in adipose tissue and insulin resistance
about
Landmark studies on the glucagon subfamily of GPCRs: from small molecule modulators to a crystal structureRole of precursor mRNA splicing in nutrient-induced alterations in gene expression and metabolismGastric inhibitory polypeptide receptor methylation in newly diagnosed, drug-naïve patients with type 2 diabetes: a case-control studyOsteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivityOsteopontin Affects Insulin Vesicle Localization and Ca2+ Homeostasis in Pancreatic Beta Cells from Female MiceGlucose-dependent insulinotropic polypeptide (GIP) and GIP receptor (GIPR) genes: An association analysis of polymorphisms and bone in young and elderly women.Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptorsThe blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight lossIncretin action in the pancreas: potential promise, possible perils, and pathological pitfalls.The Role of Osteopontin in the Pathogenesis and Complications of Type 1 Diabetes Mellitus in Children.Regulation of alternative splicing in obesity and weight loss.All-cause mortality and cardiovascular effects associated with the DPP-IV inhibitor sitagliptin compared with metformin, a retrospective cohort study on the Danish population.Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response.The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.Genetic determinants of circulating GIP and GLP-1 concentrations.
P2860
Q26798049-108F574F-D63F-47D7-9D6E-E3AB51E5594EQ26822590-A7DFFF24-A907-4758-9E27-A7014C7828D1Q28533735-F8311C79-A789-43BF-9ABA-DFDE69074C46Q33766277-2279ED34-2885-4388-AC0C-48EE508FB6A7Q34298001-36CE9076-242B-42F2-AB4A-29B80090FECCQ36255876-CB68B1F5-DDBE-451E-B3D4-6B657FC4B52AQ36317203-8DE8B3AC-608E-476D-A4F3-6EF45DDAED26Q36533318-867C1234-1D54-488C-8451-2F7863CFE4ECQ36974813-A9AE43E0-212A-4B9E-8BB4-D1E3E4DB1DB5Q37193295-06165A27-5CBA-4A5D-93F9-B5D6F9330D32Q37542237-DCE24E9C-9EAB-41A3-9E34-D803DF5C4FA8Q38132748-713962F1-7BC3-451E-96A2-F27220B13C8CQ46543039-17198D61-0065-4B52-9F95-C4DE2A64260FQ48366559-F0FA6CAF-17EB-497E-8838-534A635A9917Q49904653-54C6862B-0110-4FA5-B99A-4D0EA876E911Q52837850-AE1756DA-98C8-4DA2-8B21-DDFC8DCF6B72
P2860
Link between GIP and osteopontin in adipose tissue and insulin resistance
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Link between GIP and osteopontin in adipose tissue and insulin resistance
@en
type
label
Link between GIP and osteopontin in adipose tissue and insulin resistance
@en
prefLabel
Link between GIP and osteopontin in adipose tissue and insulin resistance
@en
P2093
P2860
P50
P356
P1433
P1476
Link between GIP and osteopontin in adipose tissue and insulin resistance
@en
P2093
Alena Stancáková
Allan Vaag
Anna V Zetterqvist
Bilal Omar
Emma Ahlqvist
Eva Degerman
Nils Wierup
Olga Kotova
Pernille Poulsen
Peter Osmark
P2860
P304
P356
10.2337/DB12-0976
P407
P50
P577
2013-01-24T00:00:00Z